Summary The goal of our study was to obtain direct evidence of co-ordinated regulation of P-glycoprotein (P-gp)-mediated multidrug resistance (MDR) and differentiation in tumour cells and to study some signalling pathways involved in joint regulation of these two cell phenotypes. The sublines of human melanoma (mS) and hepatoma (human HepG2 and rat McA RH 7777) cell lines were obtained by retroviral infection of the wild-type cells with the cDNA of the human retinoic acid receptor a (RARa). The resulting sublines stably overexpressed exogenous RARa gene. The infectants became more differentiated than the parental cells as determined by a decrease in the synthesis of the embryo-specific a-fetoprotein in HepG2 and McA RH 7777 hepatoma cells and by an increase in melanin synthesis in mS cells. The differentiation of human cells was accompanied by an increase in the amounts of MDR1 mRNA but not by an increase in P-gp activity as a drug transporter, in contrast, in the rat RARa overexpressing cells P-gp functional activity was elevated. Treatment with cytotoxic drug (colchicine) or retinoic acid (RA) resulted in a slight increase in P-gp activity in the parental and RARa-infected melanoma cells, whereas the increase in P-gp function in the infected hepatoma cells (both human and rat) was very prominent. Thus, we provide new evidence that cell differentiation caused by the overexpression of the gene participating in the differentiation programme leads to overexpression of MDR1 gene and drug resistance and that this effect is tissue and species specific. These data imply that the activation of the RA-controlled signalling pathway up-regulates MDR1 gene expression.
agents inducing cell differentiation such as all-trans-retinoic acid (RA), dimethylsulphoxide and sodium butyrate increased steadystate levels of MDR] mRNA in various cell types Mickley et al, 1989) . Also, cells of different tissue origin selected in vitro for P-gp-mediated MDR have often been shown to possess higher degrees of differentiation than their parental counterparts (Stavrovskaya et al, 1990; Alekseevskaya et al, 1993; Biedler and Spengler, 1994) . In addition, these MDR sublines were more sensitive to induction of differentiation Stromskaya et al, 1995a) .
However, in all these studies, only correlations between MDR and differentiation were investigated; direct evidence that the occurrence of differentiation causes MDR is absent. The signalling pathways participating in co-ordinated regulation of cell differentiation, MDRJ gene expression and drug resistance are unknown. Meanwhile, the alterations of the phenotype of MDR cells are numerous (Biedler and Spengler, 1994) and it cannot be excluded that changes in cell differentiation are connected not directly with MDR but with other cell changes. MDR] gene expression can be up-regulated by a wide range of chemicals and differentiation agents are only a small proportion of them (Chaudhary and Roninson, 1993) . This does not suggest that: the influence of differentiating agents on differentiation and MDR] expression is very specific.
In an attempt to obtain direct evidence of the connection between cell differentiation and MDR, we used a new approach. We obtained more differentiated cells by introduction of the gene that triggers cell differentiation and looked for different mechanisms of MDR in the stably transfected cells. Full-length cDNA of the human RARa was introduced by retroviral infection into several types of recipient cells. (Becker et al, 1976) , human melanoma mS (Stromskaya et al, 1995a) (Collins et al, 1990) . The cells (4 x 105 per 25-cm2 flask) were seeded 24 h before infection. Conditioned medium from a retrovirus-producing cell The samples with clearly visualized 18S and 28S RNA bands were used for further procedures. First-strand cDNA was synthesized using the Superscript Preamplification System (Gibco BRL) with 0.5-1.0 jg RNA as a template, 2.5 ng ml-' random hexamers, 0.5 mM of each deoxynucleotide triphosphate, 10 mm dithiothreitol and 10 U ul-l Superscript RT. The reaction was performed at 42°C for 50 min followed by inactivation of the enzyme at 70°C for 15 min. The samples were treated with 0.1 U jl-l Escherichia coli RNAase H for 20 min at 37°C, boiled and kept at -200C. Quantitative PCR analysis of MDRJ gene expression was performed using oligomers amplifying a 167-bp product; the amounts of template cDNAs were normalized by PCR amplification of P2-microglobulin cDNA (internal control) (Noonan and Roninson, 1991) . The optimal numbers of PCR cycles were 26 for the MDRJ-specific product and 20 for the Buckinghamshire, UK). Nylon membrane was allowed to dry at room temperature and was baked for 1 h at 80°C in a vacuum oven. Blots was hybridized with 32P-labelled DNA-RARa probe as described by Maniatis et al (1982) . The plasmid containing a human RARa cDNA used for 32P-labelled probe was provided by Dr SJ Collins (Fred Hutchinson Cancer Research Center) . After hybridization, the washed blot was exposed for autoradiography.
Study of cytotoxicity
The sensitivity of parental cell lines and RARcx infectants to CH was determined by the colony formation assay. The cells (2-5 x 102) were plated onto 60-mm dishes in the medium containing different concentrations of CH and incubated for 14 days. The medium was changed twice a week. The colonies of surviving cells were Giemsa stained. Cell survival was estimated as the ratio of the number of colonies at a given dose of CH to that in control (CH-free) dishes.
Transmission electron microscopy
The mS cells and their RARa-infected counterparts were grown on glass coverslips for 2 days, fixed with 2.5% glutaraldehyde in PBS, post-fixed in 1% osmium tetroxide, dehydrated in a graded ethanol series and embedded into Epon-812. Ultrathin sections were stained sequentially with uranyl acetate and lead citrate and examined in a Geol Elmiscop (GEM-1200exII) at 80 kV.
The analysis of oa-fetoprotein (AFP) expression
Immunochemical detection of AFP in HepG2, McA RH 7777 and their RARa-infected variants was performed essentially as described previously (Alekseevskaya et al, 1992 Figure 1 demonstrates the presence of the exogenous RARax transcripts in the sublines of infected cells. These infected cells express the retroviral 4.9 and 3.1 kb RARa transcripts (lanes 1, 3 and 4). The mRNA expression of the endogenous RARax transcripts in human cells Hep/neo is also visible (lane 2).
Differentiation and proliferation of RARa-infected cells The ability to produce melanin is usually considered as a marker of differentiation in melanoma cells (Filippova et al, 1983; Mishima and Imokawa, 1986 cells differ in the production of melanin, we studied these sublines using transmission electron microscopy. The mS/RAR cells became more differentiated as electron microscopy revealed larger quantities of mature premelanosomes in RARa-transformed cells than in their parental counterparts (Figure 2A and B Figure 2C ). We next studied whether the infection of hepatoma cell lines with RARa affects the number of cells producing AFP, a marker of hepatocytes in early embryo development. Plating at a low density of the control Hep/neo and 7777/neo resulted in the growth of either AFP-producing (AFP+) or AFP-negative clones (AFP-) as well as the occurrence of the colonies with both AFP+ and AFPcells (mixed clones). As shown in Figure 3, CH is a P-gp-transported drug shown to induce MDRJ gene expression in some cell types (Kohno et al, 1989; Chaudhary and Roninson, 1993) . Figure 4A (lanes 3 and 6) shows that CH (10 ng ml-1, 24 h) did not elevate MDRI expression in mS or in mS/RAR cells. However, CH-treated Hep/neo and Hep/RAR cells showed elevation of MDR] mRNA expression ( Figure 4B , lanes 3 and 6). It is noteworthy that the increase in MDR] mRNA in the control Hep/neo treated with CH was significantly greater than in mS treated with the same drugs ( Figure 4B , lane 3, compare with Figure 4A , lane 3). This difference may be connected with the tissue origin of the cells: it is known that the level ofMDR] expression in the liver is comparatively high, whereas the skin is characterized by low amounts of MDR] mRNA (Gottesman et al, 1991) .
P-gp activity in the parental and RARa-infected cells P-gp functional activity was measured by means of FACScan analysis of Rhl23 efflux from the cells (Neyfakh, 1988) . Rhl23 is a fluorescent dye that is transported by P-gp out of the cells. The cells with P-gp-mediated MDR exclude Rhl23 at a higher rate than drug-sensitive variants; so, the analysis of cell fluorescence after removal of Rhl23 from culture medium permits the comparison of P-gp functional activity in different cell populations. The Rhl23 technique is very sensitive and allows the detection of initial alterations in P-gp activity (Chaudhary and Roninson, 1992; Egudina et al, 1993) .
The results of flow cytometric experiments are presented in Figure 5 . Neither of the human RARa-infected cell lines studied demonstrated a higher rate of Rhl23 efflux than their parental counterparts ( Figure 5A and B) . In contrast, the comparison of rat hepatoma cells shows that 7777/RAR contained significantly higher amounts of Rhl23-dull cells than 7777/neo ( Figure SC) . This shows that overexpression of RARca did not change P-gp activity in the two studied human cell lines but did change it in the rat cells.
Treatment of RARa-infected cells with RA (5 gM, 48 h) led to a dramatic increase in the number of Rhl23-dull variants ( Figure  6D-F) . The effects were demonstrated for all studied cell lines, regardless of their species and tissue origin. However, the induction of P-gp-mediated efflux by RA in mS/RAR cells was less pronounced than that in Hep/RAR or 7777/RAR variants (compare Figure 6D with E and F). Interestingly, treatment of all parental cells with RA did not cause any discernible changes in P-gp function ( Figure 6A-C) .
CH (10 ng ml-1, 24 h) elevated P-gp functional activity in the control cell populations to a greater degree than RA, especially in 7777/neo culture ( Figure 6G-I) . The effect of CH on P-gp activity was much more pronounced in RARa infectants ( Figure 6J-L) . Again, as with RA treatment, the effect of CH on melanoma cells was lower than in other studied sublines. This elevation of inducibility of RARa-infected cells did not necessarily result in the acquisition of CH resistance: the comparison of mS and HepG2 sensitivity with CH revealed an almost identical IC50 for parental and infected cells (2-4 ng ml-1 CH for both cell types). However, RARa-infected rat cells (7777/RAR) became twofold resistant to CH than 7777/neo cells (IC50 for 7777/neo cells was 5 ng ml-', and 11 ng ml-' for 7777/RAR cells). These data are in agreement with our results on differences in Rhl23 efflux by parental cells and their RARa-infected counterparts.
Thus, our data show that the RARa gene increases MDR] expression but not P-gp activity in transfected cells. However the RARa gene elevates inducibility of the function of this protein by the ligand of the RARa (RA) and by the cytotoxic drug (CH).
DISCUSSION
The goal of our study was to obtain direct evidence of co-ordinated regulation of P-gp-mediated MDR and differentiation in tumour cells and to study some signalling pathways involved in joint regulation of these two cell phenotypes. Previous data show that differentiation and MDR might be connected and that MDRJ/P-gp expression may be part of the differentiation programme of the cell. However, further studies are needed to prove this supposition (discussed in the Introduction). In this study, we created more differentiated cells by introduction of the gene involved into the cell differentiation programme and investigated the various mechanisms of MDR, i.e. MDRJ expression, P-gp functional activity and cell resistance to the cytostatic drug.
We isolated the sublines of tumour cells of different species (human and rat) and tissue (hepatoma and melanoma) origin after infection with full-length cDNA of the RARcx gene. These sublines British Journal of Cancer (1998) (Kopnin et al, 1995; Stromskaya et al, 1995b) .
We next investigated whether elevated levels of MDRJ mRNA render RARac-infectants more resistant to P-gp-transported compounds. This was studied using two methods: (a) flow cytometric analysis of the efflux of Rh 123, a fluorescent dye with high affinity for P-gp, and (b) survival of the cells in the continuous presence of CH, a P-gp substrate. However, neither method revealed any activation of P-gp function in human RARa-infectants. These data indicate that overexpression of RARax does not lead to the emergence of the MDR phenotype, despite the increase in steady-state levels of MDRJ mRNA. Several explanations of these data may be proposed. First, the increase in the MDR] message is too low to confer discernible levels of MDR. Second, P-gp synthesis may undergo post-transcriptional changes; also, post-translational modifications such as phosphorylation or glycosylation may regulate P-gp-mediated drug transport. In addition, one cannot rule out the possibility that the transport of mature P-gp from the Golgi apparatus might be affected in RARcx infectants. An alternative possibility is that in RARa-infected cells, P-gp has a function unrelated to drug efflux. It is noteworthy that treatment of human neuroblastoma cells with RA induced differentiation and a concomitant overexpression of P-gp, whereas intracellular accumulation of vinblastine, vincristine or actinomycin D was not decreased . Together with our results, these data suggest that RA-activated signal transduction causes up-regulation of MDRJ gene expression but does not influence P-gp-mediated drug efflux. If that is the case, P-gp might have other physiological functions in the differentiated cells. It has been postulated that Pgp as well as other ATP-binding cassette transporters can regulate heterologous membrane channels and, perhaps, other membrane proteins . Probably, in the differentiated cells, Pgp acts as such a regulator or fulfils other functions that are necessary for maintenance of the differentiated phenotype. Recent data suggest that P-gp can function as a lipid flippase of broad specificity that translocates phospholipids across membranes (van Helvoort et al, 1996) .
Although the transport of P-gp substrates in non-stimulated RARax inlfectants was unlaffected, these sulh]ines were mrore senasitive to the induction of Rh123 efflux by RA or CH than were parental cells. This activation appeared to be tissue and species specific. In the mS and mS/RAR cells, both CH and RA caused only a slight increase in Rh 123 efflux. The continuous exposure of Hep/RAR cells to RA or CH resulted in the significant activation of Rh123 efflux. In the 7777/RAR cells the rate of induction was even higher. Moreover, only these cells among all RARa infectants demonstrated occurrence of drug resistance. These data testify that the effects of the overexpression of RARca on MDR] expression, P-gp transport and MDR are strongly dependent on cell context and are tissue and species specific.
In conclusion, our data provide new evidence that cell differentiation induced by the overexpression of the gene participating in the differentiation programme results in overexpression of the MDR] gene and may lead in some cells to elevation of P-gp functional activity and drug resistance. Prolonged treatment of RARaxinfectants with CH or RA resulted in the increase in both MDR] mRNA abundance and Rh 123 efflux to a greater extent than in the parental cells. Thus, RARa activation increases MDRJ expression and elevates inducibility of the function of this protein by the cytotoxic drug (CH) and activator (RA) of the transgene. These data imply that differentiation therapy may evoke an important consequence: it may cause the emergence of the MDR phenotype in a portion of the tumour population. Genes involved in cell differentiation and activated in the course of the therapy may elevate the rate of MDRI/P-gp response to cytotoxic drugs and thus give these cells selective advantage for survival in the course of chemotherapy.
